Table 4.
NAFLD-FS |
APRI |
FIB-4 |
BARD |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Outcome | Events (n) | Unadjusted cumulative (%)a | P value | Events (n) | Unadjusted cumulative (%)a | P value | Events (n) | Unadjusted cumulative (%)a | P value | Events (n) | Unadjusted cumulative (%)a | P value |
Liver events (n = 309) | <.001 | <.001 | <.001 | <.001 | ||||||||
Low risk | 2/125 | 1.6 | 1/90 | 1.1 | 3/111 | 2.7 | 2/119 | 1.7 | ||||
Intermediate risk | 12/115 | 10.4 | 21/162 | 13 | 4/112 | 3.6 | 23/119 | 19.3 | ||||
High risk | 29/69 | 42 | 21/57 | 36.8 | 36/86 | 41.9 | 18/71 | 25.4 | ||||
Mortality (n = 320) | <.001 | <.001 | <.001 | .01 | ||||||||
Low risk | 5/125 | 4 | 9/93 | 9.7 | 6/111 | 5.4 | 5/119 | 4.2 | ||||
Intermediate risk | 20/120 | 16.7 | 17/169 | 10 | 14/117 | 12 | 21/124 | 16.9 | ||||
High risk | 16/75 | 21.3 | 15/58 | 25.9 | 21/92 | 22.8 | 15/77 | 19.5 |
NOTE. Risk category: low risk, NAFLD-FS <–1.455; APRI <0.5; FIB-4 <1.30; BARD 0/1; moderate risk, NAFLD-FS –1.455 to 0.676; APRI 0.5 to 1.5; FIB-4 1.30 to 2.67; BARD 2/3; high risk, NAFLD-FS >0.676; APRI >1.5; FIB-4 >2.67; BARD 4.
Estimated using Kaplan-Meier analysis.